Lexaria Bioscience Corp (LEXX) is a leading packaged foods business based in Canada. In the week up to 6 June Lexaria Bioscience shares surged 13.65% to a closing position of $6.91. Over the last 12 months, Lexaria Bioscience's share price has risen by a staggering 2,178.52% from $0.298. Lexaria Bioscience is listed on the NASDAQ and employs 4 staff. All prices are listed in US Dollars.
Since the stock market crash that started in February 2020, Lexaria Bioscience's share price has had significant positive movement.
Its last market close was $6.08, which is 92.11% up on its pre-crash value of $0.48 and 2,549.24% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.2295.
If you had bought $1,000 worth of Lexaria Bioscience shares at the start of February 2020, those shares would have been worth $662.92 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $12,666.65.
|52-week range||$4.11 - $12.9|
|50-day moving average||$6.0743|
|200-day moving average||$5.8234|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-06-08)||-3.28%|
|1 month (2021-05-19)||25.74%|
|3 months (2021-03-19)||12.42%|
|6 months (2020-12-18)||2,536.89%|
|1 year (2020-06-19)||2,241.38%|
|2 years (2019-06-19)||662.92%|
|3 years (2018-06-19)||192.67%|
|5 years (2016-06-16)||7,436.07%|
|Gross profit TTM||$276,925|
|Return on assets TTM||-32.31%|
|Return on equity TTM||-35.13%|
|Market capitalisation||$34.5 million|
TTM: trailing 12 months
There are currently 398,204 Lexaria Bioscience shares held short by investors – that's known as the "short interest". This figure is 14.8% down from 467,290 last month.
There are a few different ways that this level of interest in shorting Lexaria Bioscience shares can be evaluated.
Lexaria Bioscience's "short interest ratio" (SIR) is the quantity of Lexaria Bioscience shares currently shorted divided by the average quantity of Lexaria Bioscience shares traded daily (recently around 2.5 million). Lexaria Bioscience's SIR currently stands at 0.16. In other words for every 100,000 Lexaria Bioscience shares traded daily on the market, roughly 160 shares are currently held short.
However Lexaria Bioscience's short interest can also be evaluated against the total number of Lexaria Bioscience shares, or, against the total number of tradable Lexaria Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lexaria Bioscience's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Lexaria Bioscience shares in existence, roughly 80 shares are currently held short) or 0.105% of the tradable shares (for every 100,000 tradable Lexaria Bioscience shares, roughly 105 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lexaria Bioscience.
Find out more about how you can short Lexaria Bioscience stock.
We're not expecting Lexaria Bioscience to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Lexaria Bioscience's shares have ranged in value from as little as $4.11 up to $12.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience's is 1.6641. This would suggest that Lexaria Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ever wondered how to buy shares in Gaucho Group? We explain how and compare a range of providers that can give you access to many brands, including Gaucho Group.
Ever wondered how to buy shares in AST SpaceMobile? We explain how and compare a range of providers that can give you access to many brands, including AST SpaceMobile.
Learn more about Orphazyme’s recent performance and where you can invest in Orphazyme shares. We also run through some helpful rules of thumb for any investor.
Upgrade your summer lovin’ style with the most recent release from fashion staples I Saw It First and Olivia. Shop the new collab now!
This guide will show you step-by-step instructions on how to buy the Adamant (ADDY) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Polycat Finance (FISH) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Eleven Finance (ELE) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the WaultSwap Polygon (WEXPOLY) token as well as a list of exchanges you can trade it on.
Bring the full gym experience into your home with NordicTrack’s Commercial 2950, a treadmill packed with interactive features.
Find out what we thought of NAGA, a trading platform that lets you t trade more than 500 financial instruments and copy other people’s trades.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.